Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Sponsor: Galderma R&D
Summary
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-07-14
Completion Date
2027-11-30
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Locations (108)
Galderma Investigational Site - 8893
Birmingham, Alabama, United States
Galdrma Investigational Site - 7077
Phoenix, Arizona, United States
Galderma Investigational Site 7060
Phoenix, Arizona, United States
Galderma Investigational Site - 8535
Phoenix, Arizona, United States
Galderma Investigational Site - 7067
Tucson, Arizona, United States
Galderma Investigational Site - 7074
Corona, California, United States
Galderma Investigational Site 8636
Fountain Valley, California, United States
Galderma Investigational Site 8224
Fremont, California, United States
Galderma Investigational Site 7099
Los Angeles, California, United States
Galderma Investigational Site 8553
Newport Beach, California, United States
Galderma Investigational Site 7064
Santa Monica, California, United States
Galderma Investigational Site 7107
Thousand Oaks, California, United States
Galderma Investigational Site 7061
Castle Rock, Colorado, United States
Galderma Investigational Site 7059
Fairfield, Connecticut, United States
Galderma Investigational Site 8597
Boca Raton, Florida, United States
Galderma Investigational Site 7087
Coral Gables, Florida, United States
Galderma Investigational Site 7063
Cutler Bay, Florida, United States
Galderma Investigational Site 7134
Hollywood, Florida, United States
Galderma Investigational Site 7101
Jupiter, Florida, United States
Galderma Investigational Site 7078
Miami, Florida, United States
Galderma Investigational Site 7070
North Miami Beach, Florida, United States
Galderma Investigational Site 7112
Oakland Park, Florida, United States
Galderma Investigational Site 7090
St. Petersburg, Florida, United States
Galderma Investigational Site 7054
Tampa, Florida, United States
Galderma Investigational Site 7058
Chicago, Illinois, United States
Galderma Investigational Site 8142
Indianapolis, Indiana, United States
Galderma Investigational Site 7083
West Lafayette, Indiana, United States
Galderma Investigational Site 7098
Columbia, Maryland, United States
Galderma Investigational Site 8012
Glenn Dale, Maryland, United States
Galderma Investigational Site 7068
Rockville, Maryland, United States
Galderma Investigational Site 7065
Brighton, Massachusetts, United States
Galderma Investigationa Site 7104
Milford, Massachusetts, United States
Galderma Investigational Site 7066
Auburn Hills, Michigan, United States
Galderma Investigational Site 7071
Caledonia, Michigan, United States
Galderma Investigational Site 7108
Grandville, Michigan, United States
Galderma Investigational Site 7072
Troy, Michigan, United States
Galderma Investigational Site 7057
Lee's Summit, Missouri, United States
Galderma Investigational Site 8848
Las Vegas, Nevada, United States
Galderma Investigational Site 7055
Portsmouth, New Hampshire, United States
Galderma Investigational Site - Site 7080
Auburn, New York, United States
Galderma Investigational Site # 7052
East Syracuse, New York, United States
Galderma Investigational Site - 8282
Mount Kisco, New York, United States
Galderma Investigational Site - 7051
New York, New York, United States
Galderma Investigational Site 7109
New York, New York, United States
Galderma Investigational Site 8279
New York, New York, United States
Galderma Investigational Site 7081
Dayton, Ohio, United States
Galderma Investigational Site 7073
Gresham, Oregon, United States
Galderma Investigational Site 8559
Philadelphia, Pennsylvania, United States
Galderma Investigational Site 7103
Philadelphia, Pennsylvania, United States
Galderma Investigational Site 7106
Bluffton, South Carolina, United States
Galderma Investigational Site 7082
Cedar Park, Texas, United States
Galderma Investigational Site 8238
Dallas, Texas, United States
Galderma Investigational Site 7062
Edinburg, Texas, United States
Galderma Investigational Site 7088
Grapevine, Texas, United States
Galderma Investigational Site 7069
Sugar Land, Texas, United States
Galderma Investigational Site 8618
Waco, Texas, United States
Galderma Investigational Site 7085
Bountiful, Utah, United States
Galderma Investigational Site 7079
Vienna, Virginia, United States
Galderma Investigational Site 8725
Morgantown, West Virginia, United States
Galderma Investigational Site 6374
Karlsruhe, Baden-Wurttemberg, Germany
Galderma Investigational Site 6412
Langenau, Baden-Wurttemberg, Germany
Galderma Investigational Site 6416
Augsburg, Bavaria, Germany
Galderma Investigational Site 6369
Erlangen, Bavaria, Germany
Galderma Investigational Site 6417
Regensburg, Bavaria, Germany
Galderma Investigational Site 6419
Remscheid, North Rhine-Westphalia, Germany
Galderma Investigational Site 6387
Ahaus, Germany
Galderma Investigational Site 6383
Augsburg, Germany
Galderma Investigational Site 6385
Berlin, Germany
Galderma Investigative Site 6172
Berlin, Germany
Galderma Investigational Site 6366
Berlin, Germany
Galderma Investigational Site 6398
Bernau bei Berlin, Germany
Galderma Investigational Site 6386
Bielefeld, Germany
Galderma Investigational Site 6066
Buxtehude, Germany
Galderma Investigational Site 6414
Gladbeck, Germany
Galderma Investigational Site 6418
Großenhain, Germany
Galderma Investigational Site 6370
Haslach im Kinzigtal, Germany
Galderma Investigational Site 6420
Hersbruck, Germany
Galderma Investigational Site 6384
Koblenz, Germany
Galderma Investigational Site 6013
Lübeck, Germany
Galderma Investigational Site 6373
Mainz, Germany
Galderma Investigational Site 6371
Oberursel, Germany
Galderma Investigational Site 6411
Oranienburg, Germany
Galderma Investigational Site 6390
Pforzheim, Germany
Galderma Investigational Site 6372
Quedlinburg, Germany
Galderma Investigational Site 5408
London, Hampshire, United Kingdom
Galderma Investigational Site 6401
Southampton, Hampshire, United Kingdom
Galderma Investigational Site 6399
Watford, Hertfordshire, United Kingdom
Galderma Investigational Site 6400
Kings Lynn, Norfolk, United Kingdom
Galderma Investigational Site 5131
Harrogate, North Yorkshire, United Kingdom
Galderma Investigational Site 6389
Sheffield, South Yorkshire, United Kingdom
Galderma Investigational Site 6395
London, Surrey, United Kingdom
Galderma Investigational Site 6392
Birmingham, West Midlands, United Kingdom
Galderma Investigational Site 6404
Leeds, West Yorkshire, United Kingdom
Galderma Investigational Site 6397
York, Yorkshire, United Kingdom
Galderma Investigational Site 6375
Bridgend, United Kingdom
Galderma Investigational Site 6388
Epsom, United Kingdom
Galderma Investigational Site 6394
Harrow, United Kingdom
Galderma Investigational Site 6393
Kingston upon Thames, United Kingdom
Galderma Investigational Site 6666
Kirkcaldy, United Kingdom
Galderma Investigational Site 6415
Liverpool, United Kingdom
Galderma Investigational Site 5210
London, United Kingdom
Galderma Investigational Site 6368
London, United Kingdom
Galderma Investigational Site 6396
Manchester, United Kingdom
Galderma Investigational Site 6402
Metropolitan Borough of Wirral, United Kingdom
Galderma Investigational Site 5431
Redhill, United Kingdom
Galderma Investigational Site 6403
Sandbach, United Kingdom
Galderma Investigational Site 5989
Swansea, United Kingdom
Galderma Investigational Site 5944
Wolverhampton, United Kingdom